Besides, cancer-specific PERK signaling induces cell invasion and metastasis through directly targeting CREB3L1 in breast cancer through inducing epithelial-mesenchymal transition (EMT) by an ATF4-Fra-1 interaction. Here, CREB3L1 is linked to breast cancer.